Amalgamated Bank’s Spruce Biosciences SPRB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-14
Closed -$2K 3233
2022
Q1
$2K Buy
+14
New +$2.6K ﹤0.01% 3053

Other funds holding SPRB

Amalgamated Bank's SPRB Position: Q2 2022 in Review

Amalgamated Bank sold out of Spruce Biosciences (SPRB) in Q2 2022, closing a stake of 14 shares — an estimated $2K sold.

Amalgamated Bank first reported a position in SPRB in Q1 2022 and held it in 1 quarter. The position peaked at $2K in Q1 2022. 36 funds tracked by Wall St. Rank hold SPRB as of Q2 2022.

  • Amalgamated Bank reported no remaining Spruce Biosciences position as of Q2 2022 after selling out during the quarter.
  • Amalgamated Bank sold 14 Spruce Biosciences shares in Q2 2022, an estimated $2K.
  • Amalgamated Bank first reported a position in Spruce Biosciences in Q1 2022 and held it in 1 quarter.
  • Amalgamated Bank's Spruce Biosciences position peaked at $2K in Q1 2022.
  • 36 funds tracked by Wall St. Rank held Spruce Biosciences as of Q2 2022.

Based on Amalgamated Bank's 13F filing for Q2 2022, filed 15 Aug 2022.